SpringWorks Therapeutics

Patent cliffs & loss of exclusivity

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that takes a precision medicine approach in acquiring, developing and commercializing medicines for patient populations that are suffering from rare diseases and cancer.

Company

Legal NameSpringWorks Therapeutics, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/springworks-therapeutics
Full Address100 Washington Blvd Stamford, CT 06902, USA
LinkedIn URLhttps://www.linkedin.com/company/springworks-therapeutics/
Pitchbook URLhttps://pitchbook.com/profiles/company/185814-01#overview
Seedtable URLhttps://seedtable.com/companies/springworks-therapeutics
Stock SymbolSWTX

6 upcoming patent cliffs

DrugIngredientTypeCliff
  1. OGSIVEONIROGACESTAT HYDROBROMIDESmall mol.May 2043
  2. OGSIVEONIROGACESTAT HYDROBROMIDESmall mol.May 2043
  3. OGSIVEONIROGACESTAT HYDROBROMIDESmall mol.May 2043
  4. GOMEKLIMIRDAMETINIBSmall mol.Oct 2044
  5. GOMEKLIMIRDAMETINIBSmall mol.Oct 2044
  6. GOMEKLIMIRDAMETINIBSmall mol.Oct 2044

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

SpringWorks Therapeutics — patent cliffs & loss of exclusivity | CliffBio